EcoDrugPlus

Integrin Beta-1-Like

Ensembl ID : ENSSLDG00000003954
Gene Symbol: LOC111668415
3 Cross references
228 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSSLDG00000007027
Gene Symbol: LOC111659838
3 Cross references
213 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSLDG00000002089
Gene Symbol: LOC111658453
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSSLDG00000023049
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSSLDG00000015060
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSSLDG00000020113
Gene Symbol: ITGAV
3 Cross references
237 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSSLDG00000018560
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSSLDG00000019573
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSSLDG00000009456
Gene Symbol: ITGB6
3 Cross references
187 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSLDG00000013359
Gene Symbol: ITGB8
2 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSLDG00000023042
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-6-Like

Ensembl ID : ENSSLDG00000007893
Gene Symbol: LOC111659317
2 Cross references
162 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).